Alessandrea C. Quane - 01 Mar 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
EVP, Chief Insurance Officer
Signature
/s/ Melissa Curtin, Attorney-in-Fact
Issuer symbol
OSCR
Transactions as of
01 Mar 2024
Transactions value $
-$252,937
Form type
4
Filing time
05 Mar 2024, 16:23:16 UTC
Previous filing
21 Feb 2024
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +7.02K +4.14% 176K 01 Mar 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +34.4K +19.49% 211K 01 Mar 2024 Direct F1
transaction OSCR Class A Common Stock Sale -$253K -15.9K -7.56% $15.88 195K 04 Mar 2024 Direct F2, F3
holding OSCR Class A Common Stock 76.9K 01 Mar 2024 Alessandrea C Quane 2024 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -7.02K -14.28% $0.00 42.1K 01 Mar 2024 Class A Common Stock 7.02K Direct F1, F4
transaction OSCR Restricted Stock Units Options Exercise $0 -34.4K -7.69% $0.00 413K 01 Mar 2024 Class A Common Stock 34.4K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
F5 The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.